NHS Framework for Midland & East Branded Medicines, Tranche B & Annual Tranche
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £1
- Sector
- HEALTH
- Published
- 15 Mar 2023
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
United Kingdom: Please refer to Document No. 03, Schedule 8 in the ITO Documents for the list of Purchasing Points
1 buyer
- NHS England Leeds
33 suppliers
- Sandoz Surrey
- Teva Castleford
- Roche Products Welwyn Garden City
- Kent Pharma Kent
- Ul Global Pharma Hertfordshire
- Celltrion Healthcare Slough
- Merck Sharpe & Dohme London
- Mylan Potters Bar
- Janssen Cilag Highwycombe
- Bayer Reading
- Pfizer Kent
- Neon Healthcare Hertfordshire
- Aventis Pharma Berkshire
- Ipsen Slough
- Biogen Maidenhead Berkshire
- Takeda London
- Merck Serono Middlesex
- Novo Nordisk Gatwick
- Eli Lilly Hants
- CST Pharma Walsall
- Gilead Sciences London
- Typharm Norfolk
- Amgen Cambridge
- Thornton & Ross Huddersfield
- Accord Devon
- Glaxosmithkline London
- Abbvie Berks
- Astrazeneca London
- Organon Pharmaceuticals London
- Zentiva Pharma London
- Gedeon Richter London
- Almirall Uxbridge
- Ucb Pharma Berkshire
Description
NHS Framework for Midlands and East Branded Medicines - Tranche B and Annual Tranche. Offer reference number: CM/PHR/20/5608 CM/PHR/20/5608/01 - NHS Framework for Midlands and East Branded Medicines - Tranche B. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20/5608/02 - NHS Framework for Midlands and East Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
Lot Division
| 1 | CM/PHR/20/5608/01 - NHS Framework for Midlands & East Branded - Tranche B Lot 1 - CM/PHR/20/5608/01 … Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
| 2 | CM/PHR/20/5608/02 - NHS Framework for Midlands and East Branded - Annual Lot 2 - CM/PHR/20/5608/02 … Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
Award Detail
| 1 | Sandoz (Surrey)
|
| 2 | Teva (Castleford)
|
| 3 | Roche Products (Welwyn Garden City)
|
| 4 | Kent Pharma (Kent)
|
| 5 | Ul Global Pharma (Hertfordshire)
|
| 6 | Celltrion Healthcare (Slough)
|
| 7 | Merck Sharpe & Dohme (London)
|
| 8 | Mylan (Potters Bar)
|
| 9 | Janssen Cilag (Highwycombe)
|
| 10 | Bayer (Reading)
|
| 11 | Pfizer (Kent)
|
| 12 | Neon Healthcare (Hertfordshire)
|
| 13 | Aventis Pharma (Berkshire)
|
| 14 | Ipsen (Slough)
|
| 15 | Biogen (Maidenhead Berkshire)
|
| 16 | Takeda (London)
|
| 17 | Merck Serono (Middlesex)
|
| 18 | Novo Nordisk (Gatwick)
|
| 19 | Eli Lilly (Hants)
|
| 20 | CST Pharma (Walsall)
|
| 21 | Gilead Sciences (London)
|
| 22 | Typharm (Norfolk)
|
| 23 | Teva (Castleford)
|
| 24 | Roche Products (Welwyn Garden City)
|
| 25 | Ul Global Pharma (Hertfordshire)
|
| 26 | Celltrion Healthcare (Slough)
|
| 27 | Merck Sharpe & Dohme (London)
|
| 28 | Amgen (Cambridge)
|
| 29 | Thornton & Ross (Huddersfield)
|
| 30 | Janssen Cilag (Highwycombe)
|
| 31 | Accord (Devon)
|
| 32 | Pfizer (Kent)
|
| 33 | Glaxosmithkline (London)
|
| 34 | Abbvie (Berks)
|
| 35 | Astrazeneca (London)
|
| 36 | Aventis Pharma (Berkshire)
|
| 37 | Takeda (London)
|
| 38 | Organon Pharmaceuticals (London)
|
| 39 | Zentiva Pharma (London)
|
| 40 | Novo Nordisk (Gatwick)
|
| 41 | Eli Lilly (Hants)
|
| 42 | Gedeon Richter (London)
|
| 43 | Almirall (Uxbridge)
|
| 44 | Ucb Pharma (Berkshire)
|
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** RESPONDING TO THIS NOTICE;Any supplier may be disqualified who does not respond to the following in the requisite manner:1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.ukCandidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:- agree to the user agreement- populate company details1.2) Once registered, candidates must register interest as follows:- log to the portal- select "Find Opportunities" from the supplier home screen, use the "Sort by:" facility to find this opportunity and select the bold blue title to select- review opportunity details and click "Register Interest"- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity)1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at supporthealth@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses.2) General supplier information.To manage and assess supplier information the Contracting Authority requests candidates provide theircompany profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:2.1) If not already registered (the previous sid4gov password, login and details will stillbe on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.ukand select "Register" at the top of the page.Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B.Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.D&B data will be supplied automatically by D&B.2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via themessage function on the website.OTHER CONTRACTING AUTHORITIESThe framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.
Reference
- ocds-h6vhtk-036b1b
- FTS 007473-2023